51
14) Friedmann PS. Disappearance of epidermal Langerhans cells during PUVA therapy. Br J Dermatol 1981; 105: 219-21.
15) Toyota N, Kitamura Y, Ogawa K. Administration of 8-methoxypsoralen and ultraviolet A irradiation (PUVA) induces turnover of mast cells in the skin of C57BL/6 mice. J Invest Dermatol 1990; 95: 353-8.
16) Viander M, Jansn CT, Eskola J. Influence of whole-body PUVA treatments on human peripheral blood NK cell activity. Photodermatol. 1984; 1: 23-9.
17) Seçkin D. Fotokemoterapide idame. Türkderm 2010; 44: 126-30. 18) Choi HJ, Hann SK. Livedo reticularis and livedoid vasculitis responding to PUVA
therapy. J Am Acad Dermatol. 1999; 40: 204-7. 19) Ling TC, Goulden V, Goodfield MJ. PUVA therapy in lichen aureus. J Am Acad
Dermatol. 2001; 45: 145-6. 20) Edelson R, Berger C, Gasparro F. Et al: Treatment of cutaneous T-cell lymphoma by
extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316: 297303. 21) McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R; British Photodermatology Group; UK Skin Lymphoma Group. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br J Dermatol 2006; 154: 7-20. 22) Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S; Photopheresis Expert Group. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol. 2008; 158: 659-78. 23) Krasagakis K, Dippel E, Ramaker J, Owsianowski M, Orfanos CE. Management of severe scleroderma with long-term extracorporeal photopheresis. Dermatology 1998; 196: 309-15. 24) Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, Strobl FJ, Keystone E, Mehlmauer M, Rook AH, Braverman I; Systemic sclerosis study group. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006; 54: 793-9. 25) Mathur K, Morris S, Deighan C, Green R, Douglas KW. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature. J Clin Apher 2008; 23: 144-50.



60. SAYFAYA BENZER SAYFALAR

Kutanöz T hücreli lenfoma hastalarında periferal kan CD4+ T lenfositlerde CD26 ekspresyonunun akım sitometrik yöntemle araştırılması - Sayfa 85
156-Eklund JW, Kuzel TM. Denileukin diftitox: a concise clinical review. Expert Rev Anticancer Ther 2005;5:33-38. 157-Talpur R, Duvic M. Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene. Clin Lymphoma Myeloma 2006;6:488-492. 158-Edelson RL, Berger C, Gasparso F. Treatment of cutaneous Tcell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987;316:297-303. 1...
Puva ve dar bant uvb fototerapilerinin derideki etkilerinin dermoskopla izlenmesi - Sayfa 105
61. Krutman J, Morita A. Therapeutic Photomedicine: Phototherapy. In: Freedberg MI, Eisen AZ, Wollf K, Austen FK, Goldsmith LA, Katz SI editors. Fitzpatrick’s Dermatology in General Medicine. 6th edition, New York, Mc Grawe-Hill Book Company 2003:2469-77. 62. Gereli MÇ. Melanomun Dermoskopik Tanısında 7 Özellik Kontrol Listesi İle 3 Özellik Kontrol Listesinin Karşılaştırılması İstanbul – 2006. 6...

60. SAYFADAKI ANAHTAR KELIMELER

with
therapy
dermatol
acad
cell
study


60. SAYFA ICERIGI

51
14) Friedmann PS. Disappearance of epidermal Langerhans cells during PUVA therapy. Br J Dermatol 1981; 105: 219-21.
15) Toyota N, Kitamura Y, Ogawa K. Administration of 8-methoxypsoralen and ultraviolet A irradiation (PUVA) induces turnover of mast cells in the skin of C57BL/6 mice. J Invest Dermatol 1990; 95: 353-8.
16) Viander M, Jansn CT, Eskola J. Influence of whole-body PUVA treatments on human peripheral blood NK cell activity. Photodermatol. 1984; 1: 23-9.
17) Seçkin D. Fotokemoterapide idame. Türkderm 2010; 44: 126-30. 18) Choi HJ, Hann SK. Livedo reticularis and livedoid vasculitis responding to PUVA
therapy. J Am Acad Dermatol. 1999; 40: 204-7. 19) Ling TC, Goulden V, Goodfield MJ. PUVA therapy in lichen aureus. J Am Acad
Dermatol. 2001; 45: 145-6. 20) Edelson R, Berger C, Gasparro F. Et al: Treatment of cutaneous T-cell lymphoma by
extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316: 297303. 21) McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R; British Photodermatology Group; UK Skin Lymphoma Group. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br J Dermatol 2006; 154: 7-20. 22) Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, Juvonen E, Marshall S; Photopheresis Expert Group. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol. 2008; 158: 659-78. 23) Krasagakis K, Dippel E, Ramaker J, Owsianowski M, Orfanos CE. Management of severe scleroderma with long-term extracorporeal photopheresis. Dermatology 1998; 196: 309-15. 24) Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, Strobl FJ, Keystone E, Mehlmauer M, Rook AH, Braverman I; Systemic sclerosis study group. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006; 54: 793-9. 25) Mathur K, Morris S, Deighan C, Green R, Douglas KW. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature. J Clin Apher 2008; 23: 144-50.

İlgili Kaynaklar

single.php